Graziella Guariso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Graziella Guariso has a total of 482 co-authors. Here are the top co-authors by number of shared publications:
- Daniela Basso
Laboratory Medicine Unit , Integrated Diagnostic Services – DIDAS, Padova University Hospital , Padova , Italy
14 shared publications - Carlo-Federico Zambon
Department of Medicine, University of Padova, Padova, Italy
10 shared publications - Marco Gasparetto
Department of Paediatric Gastroenterology Jenny Lind Children's Hospital, Norfolk and Norwich University Hospitals, Faculty of Medicine and Health Science University of East Anglia (UEA) Norwich UK
8 shared publications Mario Plebani
8 shared publicationsLucia Zancan
Unit of Gastroenterology Department of Paediatrics Italy
7 shared publicationsPaola Fogar
7 shared publications
Latest Publications
- 1 September 2014
- Published by Elsevier in Digestive and Liver Disease
- Vol. 46, e77
Fata junior gastro SIGENP: A first Italian survey on nonsteroidal anti-inflammatory drugs (NSAID) and upper gastrointestinal bleeding in children
- 1 September 2014
- Published by Elsevier in Digestive and Liver Disease
- Vol. 46, e77
Fata junior gastro SIGENP: A first Italian survey on nonsteroidal anti-inflammatory drugs (NSAID) and upper gastrointestinal bleeding in children
- 1 September 2014
- Published by Elsevier in Digestive and Liver Disease
- Vol. 46, e75-e76
Infant feeding pattern, HLA status, and prevalence of celiac disease
- 1 September 2014
- Published by Elsevier in Digestive and Liver Disease
- Vol. 46, e75-e76
Infant feeding pattern, HLA status, and prevalence of celiac disease
- 1 September 2014
- Published by Elsevier in Digestive and Liver Disease
- Vol. 46, e71-e72
Extra-hepatic portal vein obstruction in children: A multicentre national study
- 1 September 2014
- Published by Elsevier in Digestive and Liver Disease
- Vol. 46, e71-e72
Extra-hepatic portal vein obstruction in children: A multicentre national study
- Open Access
- 28 May 2014
- Published by Hindawi Limited in Gastroenterology Research and Practice
- Vol. 2014, 1-2
Epidemiology and Natural History of IBD in the Paediatric Age
- 28 May 2014
- Published by Hindawi Limited in Gastroenterology Research and Practice
- Vol. 2014, 1-2
Open AccessEpidemiology and Natural History of IBD in the Paediatric Age
- Open Access
- 24 December 2013
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2013, 1-12
Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age
Background. The number of patients of all age brackets diagnosed with Inflammatory Bowel Disease (IBD) has risen dramatically worldwide over the past 50 years. IBD’s changing epidemiology suggests that environmental factors play a major role in modifying disease expression.Aim. To review studies carried out worldwide analyzing IBD epidemiology.Methods. A Medline search indicating as keywords “Inflammatory Bowel Disease,” “epidemiology,” “natural history,” “Crohn’s Disease,” “Ulcerative Colitis,” and “IBD Unclassified” was performed. A selection of clinical cohort and systematic review studies that were carried out between 2002 and 2013 was reviewed. Studies referring to an earlier date were also considered whenever the data were relevant to our review.Results. The current mean prevalence of IBD in the total population of Western countries is estimated at 1/1,000. The highest prevalence and incidence rates of IBD worldwide are reported from Canada. Just as urbanization and socioeconomic development, the incidence of IBD is rising in China.Conclusions. Multicenter national registers and international networks can provide information on IBD epidemiology and lead to hypotheses about its causes and possible management strategies. The rising trend in the disease’s incidence in developing nations suggests that its epidemiological evolution is linked to industrialization and modern Westernized lifestyles.
- 24 December 2013
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2013, 1-12
Open AccessHighlights in IBD Epidemiology and Its Natural History in the Paediatric Age
Background. The number of patients of all age brackets diagnosed with Inflammatory Bowel Disease (IBD) has risen dramatically worldwide over the past 50 years. IBD’s changing epidemiology suggests that environmental factors play a major role in modifying disease expression.Aim. To review studies carried out worldwide analyzing IBD epidemiology.Methods. A Medline search indicating as keywords “Inflammatory Bowel Disease,” “epidemiology,” “natural history,” “Crohn’s Disease,” “Ulcerative Colitis,” and “IBD Unclassified” was performed. A selection of clinical cohort and systematic review studies that were carried out between 2002 and 2013 was reviewed. Studies referring to an earlier date were also considered whenever the data were relevant to our review.Results. The current mean prevalence of IBD in the total population of Western countries is estimated at 1/1,000. The highest prevalence and incidence rates of IBD worldwide are reported from Canada. Just as urbanization and socioeconomic development, the incidence of IBD is rising in China.Conclusions. Multicenter national registers and international networks can provide information on IBD epidemiology and lead to hypotheses about its causes and possible management strategies. The rising trend in the disease’s incidence in developing nations suggests that its epidemiological evolution is linked to industrialization and modern Westernized lifestyles.
- 1 June 2013
- Published by Elsevier in Clinica Chimica Acta
- Vol. 421, 202-207
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: A comparative study
- 1 June 2013
- Published by Elsevier in Clinica Chimica Acta
- Vol. 421, 202-207
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: A comparative study
- Open Access
Update on Peptic Ulcers in the Pediatric Age
Background. Peptic ulcer disease (PUD) in children is reported worldwide, although it is relatively rare as compared with adults. Helicobacter pylori (HP) infection is a common cause of PUD in the pediatric age. Other risk factors include the use of nonsteroidal anti-inflammatory agents (NSAIDs), steroids, immunosuppressive drugs, and stressful events. Aim. To critically review the evidence on epidemiology, diagnostic management, and available treatments for PUD in the pediatric age. Methods. A MEDLINE search was performed indicating keywords as “Peptic Ulcer Disease,” “Epidemiology,” “Pediatric,” “Helicobacter pylori,” “Gastric ulcer,” “Bulbar Ulcer,” and “Upper Gastrointestinal Bleeding.” A selection of clinical trials, systematic reviews, and meta-analyses within the time period 2002–2012 was performed. Results. PUD in children is reported worldwide with an estimated frequency of 8.1% in Europe and of 17.4% in the US. When the underlying cause of PUD is addressed, the prognosis is excellent. Standard triple therapy, bismuth-based quadruple therapy, and the sequential therapy represent the current recommended treatments for HP related ulcers. NSAIDs related ulcers are treated by stopping the causative medications and by administration of proton-pump inhibitors or antisecretory drugs. Conclusions. PUD still represents a major concern in the paediatric age. A careful differential diagnosis and an adequate treatment constitute an excellent prognosis.
Open AccessUpdate on Peptic Ulcers in the Pediatric Age
Background. Peptic ulcer disease (PUD) in children is reported worldwide, although it is relatively rare as compared with adults. Helicobacter pylori (HP) infection is a common cause of PUD in the pediatric age. Other risk factors include the use of nonsteroidal anti-inflammatory agents (NSAIDs), steroids, immunosuppressive drugs, and stressful events. Aim. To critically review the evidence on epidemiology, diagnostic management, and available treatments for PUD in the pediatric age. Methods. A MEDLINE search was performed indicating keywords as “Peptic Ulcer Disease,” “Epidemiology,” “Pediatric,” “Helicobacter pylori,” “Gastric ulcer,” “Bulbar Ulcer,” and “Upper Gastrointestinal Bleeding.” A selection of clinical trials, systematic reviews, and meta-analyses within the time period 2002–2012 was performed. Results. PUD in children is reported worldwide with an estimated frequency of 8.1% in Europe and of 17.4% in the US. When the underlying cause of PUD is addressed, the prognosis is excellent. Standard triple therapy, bismuth-based quadruple therapy, and the sequential therapy represent the current recommended treatments for HP related ulcers. NSAIDs related ulcers are treated by stopping the causative medications and by administration of proton-pump inhibitors or antisecretory drugs. Conclusions. PUD still represents a major concern in the paediatric age. A careful differential diagnosis and an adequate treatment constitute an excellent prognosis.
- Open Access
- 29 September 2012
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2012, 1-4
Colonic Perforation in a Child with Crohn's Disease: Successful Medical Treatment Rescues from Colectomy
Background. The challenging treatment of penetrating paediatric Crohn’s disease (CD) involves pharmacological and surgical approaches. Despite a proved efficacy of anti-TNF agents for treatment of complex fistula, a large number of patients cannot achieve a complete healing and relapse during the followup.Aim. We report a paediatric case with CD and colonic perforation who was successfully treated with medical therapy only, including anti-TNFα.Case Presentation. During a colonoscopy performed on a 9-year-old girl with CD, a perforation occurred in correspondence of a fistula at the colonic splenic flexure. The formation of a collection was then detected (US, enteric-CT), as well as a fistula connecting the colon to the collection. The girl was kept fasting and treated with total parenteral nutrition and antibiotic therapy. Treatment with Infliximab was also started, and after the third dose a US control showed disappearance of the collection and healing of the enteric fistula. Parenteral nutrition was progressively substituted with enteral feeding, and no surgical treatments were needed.Discussion. In pubertal children with penetrating CD, the option of an efficacious medical treatment to avoid a major surgical approach on the bowel is to be aimed for growth improvement. This approach requires a strictly monitored long-term followup.
- 29 September 2012
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2012, 1-4
Open AccessColonic Perforation in a Child with Crohn's Disease: Successful Medical Treatment Rescues from Colectomy
Background. The challenging treatment of penetrating paediatric Crohn’s disease (CD) involves pharmacological and surgical approaches. Despite a proved efficacy of anti-TNF agents for treatment of complex fistula, a large number of patients cannot achieve a complete healing and relapse during the followup.Aim. We report a paediatric case with CD and colonic perforation who was successfully treated with medical therapy only, including anti-TNFα.Case Presentation. During a colonoscopy performed on a 9-year-old girl with CD, a perforation occurred in correspondence of a fistula at the colonic splenic flexure. The formation of a collection was then detected (US, enteric-CT), as well as a fistula connecting the colon to the collection. The girl was kept fasting and treated with total parenteral nutrition and antibiotic therapy. Treatment with Infliximab was also started, and after the third dose a US control showed disappearance of the collection and healing of the enteric fistula. Parenteral nutrition was progressively substituted with enteral feeding, and no surgical treatments were needed.Discussion. In pubertal children with penetrating CD, the option of an efficacious medical treatment to avoid a major surgical approach on the bowel is to be aimed for growth improvement. This approach requires a strictly monitored long-term followup.
- Open Access
- 1 August 2012
- Published by Elsevier in Gastroenterology
- Vol. 143 (2) , 347-355
Loss of Interleukin-10 Signaling and Infantile Inflammatory Bowel Disease: Implications for Diagnosis and Therapy
- 1 August 2012
- Published by Elsevier in Gastroenterology
- Vol. 143 (2) , 347-355
Open AccessLoss of Interleukin-10 Signaling and Infantile Inflammatory Bowel Disease: Implications for Diagnosis and Therapy